Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Ureteral Neoplasms × Denosumab × Clear all

Sponsor

Conditions

Breast Neoplasms 11 Neoplasms 8 Prostatic Neoplasms 6 Multiple Myeloma 5 Fractures, Bone 4 Neoplasm Metastasis 3 Bone Diseases, Metabolic 3 Spinal Cord Compression 2 Parathyroid Neoplasms 2 Osteoporosis 2 Lymphoma 2 Carcinoma, Non-Small-Cell Lung 2 Thyroid Neoplasms 1 Smoldering Multiple Myeloma 1 Paraproteinemias 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplastic Processes 1 Neoplastic Cells, Circulating 1 Neoplasms, Plasma Cell 1 Multiple Endocrine Neoplasia Type 1 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Kidney Neoplasms 1 Hyperparathyroidism, Primary 1 Hypercalcemia 1 Humoral Hypercalcemia Of Malignancy 1 Hormone Refractory Prostate Cancer 1 Hodgkin Disease 1

Interventions

Gemcitabine 5 Cisplatin 4 enfortumab vedotin 2 Ramucirumab 2 Platinum 2 Docetaxel 2 1,2-diaminocyclohexaneplatinum II citrate 2 vinflunine 1 rucaparib 1 pembrolizumab 1 eribulin 1 enzalutamide 1 dehydroftorafur 1 carotuximab 1 avelumab 1 atezolizumab 1 Standard of Care 1 Specimen Handling 1 Radiotherapy 1 Radiation 1 Paclitaxel 1 N-(3-aminopropyl)-N-(1-(5-benzyl-3-methyl-4-oxo-(1,2)thiazolo(5,4-d)pyrimidin-6-yl)-2-methylpropyl)-4-methylbenzamide 1 Mitozytrex 1 Mitomycin 1 Magnetic Resonance Spectroscopy 1 Interleukin-7 1 Immunoglobulin G 1 Icrucumab 1 IMC-18F1 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡